The Pharma Navigator - Navigating The Key News Stories In Pharma

View Original

Sanner Group Announces Construction Milestone at New Global Headquarters and Production Site

The Sanner Group announced the completion of the structural phase of its new headquarters and development and production site in Bensheim, Germany. The company will go on to fit out the site, and said it expects it will work closely with customers to move all production into the new facility by the beginning of 2025.

Sanner Group announces that it has held a “Topping Out” ceremony at its new headquarters and production/development site, located in Bensheim, Germany. The “Topping Out” ceremony marking a critical milestone was held on October 19th, 2023 following the completion of the main structural building process. The building’s aggressive construction plan has remained on schedule since the initial groundbreaking held on January 21, 2023. Receiving the manufacturing equipment transfers from September 2024 on at the state-of-the-art production facility, Sanner will work closely with customers to move all production into the new facility by beginning of 2025.

The building project is designed and managed by Goldbeck GmbH, one of Germany’s leading industrial construction companies. Deutsche Anlagen-Leasing (DAL), a leading specialist in large-scale asset-based investment projects, with a transaction volume of over 2.4 billion euros, is financing the project which will effectively double Sanner’s existing production capacity in Germany.

The new 30,000 square meter (322,917 square foot) facility will house a flexible injection molding and assembly hall that can meet packaging and device CDMO requirements. The facility was designed with an automated central material supply system to support efficient machine loading. Other facility design features include Electrostatic Discharge (ESD) floors for assembly of devices that include electronic medical technology components, and Class 7 clean rooms. Current storage capacity will double with the addition of the new warehouse that will soon implement a fully automated warehouse management system to enhance efficiency. The new site will also include a 300 square meter (3229 square foot) “Sanner Technikum” technology and innovation center that will develop customer-specific solutions and device prototypes on site.

The new building is designed to meet Sanner’s sustainability objectives, through the incorporation numerous features contributing to the long-term sustainability of the site. A significant portion of the energy required to run the site will be generated by the Photovoltaic system covering the entire factory roof, that converts thermal energy directly into electricity. Further energy requirements will come from energy efficient heat pumps, and wind turbines to support the outdoor lighting and electric bicycle and car charging stations. Utilizing modern isolation systems and state-of-the-art machinery reduces energy consumption as well. Sanner also took a green approach to the site grounds with the introduction of many trees and a green roof contributing to a more sustainable production facility.

The new facility in Bensheim represents a lighthouse project for Sanner and the future of sustainable manufacturing with energy and resource-efficient operations. The Bensheim site construction is an important part of a greater expansion plan for the Sanner Group, which includes a new second facility in Kunshan, China. The expansion plan will enable the company to fulfill its strategic goals of providing pharma and nutraceutical desiccant packaging as well as medical CDMO services, with the best quality and flexibility for its customers. Sanner’s key objective is to provide next to the packaging portfolio exceptional and efficient development and production of drug delivery, diagnostic and medtech devices for customers around the globe.

“This day is the next great milestone in our company’s history, noted Sanner CEO Dr. Hans-Willem van Vliet. “This outstanding facility is the result of the hard work and dedication of many people, all of whom deserve great thanks. After all, this is where the Sanner Group will accelerate the development of pharma and medical technologies and provide smart solutions that benefit customers and patients. I strongly believe that the new facilities, as well as our current expansion efforts in Europe and the U.S., will lead to further profitable growth and sustainable capacity for the Sanner Group.”

For more, please find the original story source here.